• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of effective vaccines for enterotoxigenic Escherichia coli.

作者信息

Seo Hyesuk, Zhang Weiping

机构信息

Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.

Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.

出版信息

Lancet Infect Dis. 2020 Feb;20(2):150-152. doi: 10.1016/S1473-3099(19)30631-0. Epub 2019 Nov 19.

DOI:10.1016/S1473-3099(19)30631-0
PMID:31757775
Abstract
摘要

相似文献

1
Development of effective vaccines for enterotoxigenic Escherichia coli.产肠毒素大肠杆菌有效疫苗的研发
Lancet Infect Dis. 2020 Feb;20(2):150-152. doi: 10.1016/S1473-3099(19)30631-0. Epub 2019 Nov 19.
2
Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development.为产肠毒素大肠杆菌疫苗研发提供架构。
J Infect Dis. 2017 Jul 1;216(1):1-3. doi: 10.1093/infdis/jix146.
3
Enterotoxigenic Escherichia coli: advances in technical and laboratory aspects of research and development of vaccines.产肠毒素大肠杆菌：疫苗研发技术与实验室研究进展
Wkly Epidemiol Rec. 2008 Mar 7;83(10):92-5.
4
Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.高免牛初乳抗 CS17 抗体在随机、双盲、安慰剂对照的人体感染模型中预防肠产毒性大肠杆菌腹泻。
J Infect Dis. 2019 Jul 2;220(3):505-513. doi: 10.1093/infdis/jiz135.
5
Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.肠致病性大肠杆菌的致病机制及疫苗研究进展
Microb Pathog. 2018 Apr;117:162-169. doi: 10.1016/j.micpath.2018.02.032. Epub 2018 Feb 21.
6
Recent progress toward an enterotoxigenic Escherichia coli vaccine.肠毒素性大肠杆菌疫苗的最新研究进展。
Expert Rev Vaccines. 2012 Apr;11(4):495-507. doi: 10.1586/erv.12.12.
7
[Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].[新型抗人肠产毒性大肠杆菌疫苗的研究进展——综述]
Wei Sheng Wu Xue Bao. 2016 Feb 4;56(2):198-208.
8
An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.婴幼儿产肠毒素大肠杆菌和志贺氏菌候选疫苗评估。
Vaccine. 2015 Feb 18;33(8):954-65. doi: 10.1016/j.vaccine.2014.11.049. Epub 2014 Dec 5.
9
Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.肠产毒性大肠埃希菌耐热肠毒素结合物免疫小鼠可产生中和毒素的抗体，该抗体与鸟苷酸环化酶 C 激动剂和尿鸟苷酸环化酶 G 激动剂也发生交叉反应。
Infect Immun. 2019 Jun 20;87(7). doi: 10.1128/IAI.00099-19. Print 2019 Jul.
10
A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea - dose optimization, clinical outcomes, and CD4+ T cell responses.一种用于测试基于耐热毒素的肠产毒性大肠杆菌腹泻疫苗候选物的新型人体挑战模型——剂量优化、临床结果和 CD4+T 细胞反应。
PLoS Negl Trop Dis. 2019 Oct 30;13(10):e0007823. doi: 10.1371/journal.pntd.0007823. eCollection 2019 Oct.

引用本文的文献

1
Single domain antibodies from camelids in the treatment of microbial infections.骆驼科单域抗体在治疗微生物感染中的应用。
Front Immunol. 2024 May 17;15:1334829. doi: 10.3389/fimmu.2024.1334829. eCollection 2024.
2
Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic .重组乳酸菌活载体口服疫苗在预防F4 +产肠毒素菌方面的应用
Vaccines (Basel). 2024 Mar 14;12(3):304. doi: 10.3390/vaccines12030304.
3
Production of monoclonal antibody of heat-labile toxin A subunit to identify enterotoxigenic by epitope mapping using synthetic peptides.
利用合成肽进行表位作图鉴定产肠毒素性的不耐热毒素 A 亚单位单克隆抗体的生产。
Front Immunol. 2023 May 18;14:1152910. doi: 10.3389/fimmu.2023.1152910. eCollection 2023.
4
Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX Vaccine-Induced IgG Antibodies in Zambian Children.使用肠毒素大肠杆菌蛋白质组微阵列评估赞比亚儿童中ETVAX疫苗诱导的IgG抗体的交叉反应性。
Vaccines (Basel). 2023 May 4;11(5):939. doi: 10.3390/vaccines11050939.
5
The Diversity of Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen.针对这种多面性细菌病原体的致病型多样性及疫苗接种策略
Microorganisms. 2023 Jan 30;11(2):344. doi: 10.3390/microorganisms11020344.
6
Enterotoxigenic : intestinal pathogenesis mechanisms and colonization resistance by gut microbiota.肠毒素性的：肠道发病机制和肠道微生物群的定植抵抗。
Gut Microbes. 2022 Jan-Dec;14(1):2055943. doi: 10.1080/19490976.2022.2055943.
7
Sequence variations in the ETEC CS6 operon affect transcript and protein expression.ETEC CS6 操纵子中的序列变异影响转录本和蛋白表达。
Virulence. 2021 Dec;12(1):2659-2669. doi: 10.1080/21505594.2021.1981000.
8
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.抗 CfaE 纳米抗体为主要致病性肠产毒大肠杆菌菌株提供广泛的交叉保护，这对疫苗设计具有重要意义。
Sci Rep. 2021 Feb 2;11(1):2751. doi: 10.1038/s41598-021-81895-0.
9
Vaccines against gastroenteritis, current progress and challenges.针对肠胃炎的疫苗：当前的进展和挑战。
Gut Microbes. 2020 Nov 1;11(6):1486-1517. doi: 10.1080/19490976.2020.1770666. Epub 2020 Jun 18.